PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,642 | +24.0% | 34,255 | +0.4% | 0.00% | – |
| Q2 2023 | $39,220 | +16.5% | 34,104 | +7.4% | 0.00% | – |
| Q1 2023 | $33,666 | -26.7% | 31,760 | +5.2% | 0.00% | – |
| Q4 2022 | $45,909 | -24.7% | 30,203 | +5.5% | 0.00% | – |
| Q3 2022 | $61,000 | +64.9% | 28,637 | +4.1% | 0.00% | – |
| Q2 2022 | $37,000 | -55.4% | 27,513 | -29.8% | 0.00% | – |
| Q1 2022 | $83,000 | -55.1% | 39,177 | -21.3% | 0.00% | – |
| Q4 2021 | $185,000 | -34.2% | 49,801 | -11.5% | 0.00% | -100.0% |
| Q3 2021 | $281,000 | -30.1% | 56,298 | -8.7% | 0.00% | 0.0% |
| Q2 2021 | $402,000 | +24.8% | 61,676 | +32.1% | 0.00% | 0.0% |
| Q1 2021 | $322,000 | -27.1% | 46,686 | +7.8% | 0.00% | -50.0% |
| Q4 2020 | $442,000 | +250.8% | 43,293 | +20.6% | 0.00% | +100.0% |
| Q3 2020 | $126,000 | -30.8% | 35,886 | -1.4% | 0.00% | 0.0% |
| Q2 2020 | $182,000 | +100.0% | 36,380 | +36.5% | 0.00% | 0.0% |
| Q1 2020 | $91,000 | – | 26,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |